79 related articles for article (PubMed ID: 38742117)
1. Development of an anoikis-related gene signature and prognostic model for predicting the tumor microenvironment and response to immunotherapy in colorectal cancer.
Li C; Weng J; Yang L; Gong H; Liu Z
Front Immunol; 2024; 15():1378305. PubMed ID: 38779664
[TBL] [Abstract][Full Text] [Related]
2. Identification of the molecular subtypes and signatures to predict the prognosis, biological functions, and therapeutic response based on the anoikis-related genes in colorectal cancer.
Zhai X; Chen B; Hu H; Deng Y; Chen Y; Hong Y; Ren X; Jiang C
Cancer Med; 2024 May; 13(10):e7315. PubMed ID: 38785271
[TBL] [Abstract][Full Text] [Related]
3. Anoikis-related gene signatures in colorectal cancer: implications for cell differentiation, immune infiltration, and prognostic prediction.
Ding T; Shang Z; Zhao H; Song R; Xiong J; He C; Liu D; Yi B
Sci Rep; 2024 May; 14(1):11525. PubMed ID: 38773226
[TBL] [Abstract][Full Text] [Related]
4. Integration of single-cell sequencing and bulk RNA-seq to identify and develop a prognostic signature related to colorectal cancer stem cells.
Wu J; Li W; Su J; Zheng J; Liang Y; Lin J; Xu B; Liu Y
Sci Rep; 2024 May; 14(1):12270. PubMed ID: 38806611
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a T cell proliferation-associated regulator signature correlates with prognosis risk and immunotherapy response in bladder cancer.
Yan T; Zhou W; Li C
Int Urol Nephrol; 2024 May; ():. PubMed ID: 38789872
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of a novel subtype of immune microenvironment-derived HPV-infected colorectal cancer.
Zhou J; Liu Y; Zhang Y; Ling F; Zheng J; Yao X; Lyu Z; Feng H; Li Y
Microbes Infect; 2024; 26(4):105315. PubMed ID: 38417673
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6-Positive Immune Cells as a Possible New Immunologic Marker Associated With the Colorectal Cancer Prognosis.
Gulubova M; Chonov D; Aleksandrova E; Ivanova K; Ignatova MM; Vlaykova T
Appl Immunohistochem Mol Morphol; 2024 May-Jun 01; 32(5):233-243. PubMed ID: 38712586
[TBL] [Abstract][Full Text] [Related]
8. Spatial and single-cell colocalisation analysis reveals MDK-mediated immunosuppressive environment with regulatory T cells in colorectal carcinogenesis.
Hashimoto M; Kojima Y; Sakamoto T; Ozato Y; Nakano Y; Abe T; Hosoda K; Saito H; Higuchi S; Hisamatsu Y; Toshima T; Yonemura Y; Masuda T; Hata T; Nagayama S; Kagawa K; Goto Y; Utou M; Gamachi A; Imamura K; Kuze Y; Zenkoh J; Suzuki A; Takahashi K; Niida A; Hirose H; Hayashi S; Koseki J; Fukuchi S; Murakami K; Yoshizumi T; Kadomatsu K; Tobo T; Oda Y; Uemura M; Eguchi H; Doki Y; Mori M; Oshima M; Shibata T; Suzuki Y; Shimamura T; Mimori K
EBioMedicine; 2024 May; 103():105102. PubMed ID: 38614865
[TBL] [Abstract][Full Text] [Related]
9. Multiregional transcriptomics identifies congruent consensus subtypes with prognostic value beyond tumor heterogeneity of colorectal cancer.
Langerud J; Eilertsen IA; Moosavi SH; Klokkerud SMK; Reims HM; Backe IF; Hektoen M; Sjo OH; Jeanmougin M; Tejpar S; Nesbakken A; Lothe RA; Sveen A
Nat Commun; 2024 May; 15(1):4342. PubMed ID: 38773143
[TBL] [Abstract][Full Text] [Related]
10. Multistain deep learning for prediction of prognosis and therapy response in colorectal cancer.
Foersch S; Glasner C; Woerl AC; Eckstein M; Wagner DC; Schulz S; Kellers F; Fernandez A; Tserea K; Kloth M; Hartmann A; Heintz A; Weichert W; Roth W; Geppert C; Kather JN; Jesinghaus M
Nat Med; 2023 Feb; 29(2):430-439. PubMed ID: 36624314
[TBL] [Abstract][Full Text] [Related]
11. An inflammation-related subtype classification for analyzing tumor microenvironment and clinical prognosis in colorectal cancer.
Pei J; Gao Y; Wu A
Front Immunol; 2024; 15():1369726. PubMed ID: 38742117
[TBL] [Abstract][Full Text] [Related]
12. Role of Interleukins in Inflammation-Mediated Tumor Immune Microenvironment Modulation in Colorectal Cancer Pathogenesis.
Jain SM; Deka D; Das A; Paul S; Pathak S; Banerjee A
Dig Dis Sci; 2023 Aug; 68(8):3220-3236. PubMed ID: 37277647
[TBL] [Abstract][Full Text] [Related]
13. Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive Inflammation.
Salla M; Guo J; Joshi H; Gordon M; Dooky H; Lai J; Capicio S; Armstrong H; Valcheva R; Dyck JRB; Thiesen A; Wine E; Dieleman LA; Baksh S
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983040
[TBL] [Abstract][Full Text] [Related]
14. Cancer statistics, 2023.
Siegel RL; Miller KD; Wagle NS; Jemal A
CA Cancer J Clin; 2023 Jan; 73(1):17-48. PubMed ID: 36633525
[TBL] [Abstract][Full Text] [Related]
15. Genetic and Epigenetic Etiology of Inflammatory Bowel Disease: An Update.
Jarmakiewicz-Czaja S; Zielińska M; Sokal A; Filip R
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553655
[TBL] [Abstract][Full Text] [Related]
16. Metabolism and Colorectal Cancer.
Sedlak JC; Yilmaz ÖH; Roper J
Annu Rev Pathol; 2023 Jan; 18():467-492. PubMed ID: 36323004
[TBL] [Abstract][Full Text] [Related]
17. Regulatory T-cell development in the tumor microenvironment.
Itahashi K; Irie T; Nishikawa H
Eur J Immunol; 2022 Aug; 52(8):1216-1227. PubMed ID: 35879813
[TBL] [Abstract][Full Text] [Related]
18. Markers of Immune Cell Exhaustion as Predictor of Survival in Surgically-Treated Early-Stage NSCLC.
Sellmer L; Kovács J; Walter J; Kumbrink J; Neumann J; Kauffmann-Guerrero D; Kiefl R; Schneider C; Jung A; Behr J; Tufman A
Front Immunol; 2022; 13():858212. PubMed ID: 35833140
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
